Literature DB >> 2168342

Risk factors for hepatocellular carcinoma in Catalonia, Spain.

M V Mayans1, X Calvet, J Bruix, M Bruguera, J Costa, J Estève, F X Bosch, C Bru, J Rodés.   

Abstract

The influence of hepatitis B virus infection, alcohol consumption, tobacco smoking and use of oral contraceptives on the risk of hepatocellular carcinoma (HCC) was evaluated in a hospital-based case-control study in Catalonia, in the Mediterranean coastal area of north-eastern Spain. A total of 96 HCC cases (86.5% of them with associated liver cirrhosis) and 190 age- and sex-matched controls were studied. The odds ratio of HCC and 95% confidence interval among hepatitis B surface antigen (HBsAg) carriers was 4.9 (1.3-21.9). The OR was not significantly elevated in smokers, and a marginally significant increased risk was found among users of oral contraceptives based on 6 female cases. There was a significant dose-response relationship between alcohol consumption and risk of HCC (chi 2 for trend: 24.3, p less than 0.001). Although hepatitis B infection was strongly associated with HCC, alcohol abuse leading to cirrhosis appears to be one of the main causes of HCC in this region.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168342     DOI: 10.1002/ijc.2910460307

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

1.  Etiology of primary liver cancer and the role of steroidal hormones.

Authors:  D Trichopoulos
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

Review 2.  Oral contraceptives and cancer. A review of the evidence.

Authors:  C La Vecchia; A Tavani; S Franceschi; F Parazzini
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

3.  Autoantibody responses in Chinese hepatocellular carcinoma.

Authors:  Jian-Ying Zhang; Xiao Wang; Xuan-Xian Peng; Edward K L Chan
Journal:  J Clin Immunol       Date:  2002-03       Impact factor: 8.317

4.  Prospective study of the association of alcohol with cancer of the upper aerodigestive tract and other sites.

Authors:  I Kato; A M Nomura; G N Stemmermann; P H Chyou
Journal:  Cancer Causes Control       Date:  1992-03       Impact factor: 2.506

5.  Association between Hepatitis B Virus X Gene Mutations and Clinical Status in Patients with Chronic Hepatitis B Infection.

Authors:  Eun Young Cho; Chang Soo Choi; Ji-Hyun Cho; Haak Cheoul Kim
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

6.  Epidemiology of primary and secondary liver cancers.

Authors:  Ashwin Ananthakrishnan; Veena Gogineni; Kia Saeian
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

7.  Oral contraceptives and primary liver cancer among young women.

Authors:  A W Hsing; R N Hoover; J K McLaughlin; H T Co-Chien; S Wacholder; W J Blot; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

8.  Primary liver cancer in a high-incidence area in north Italy: etiological hypotheses arising from routinely collected data.

Authors:  R Chiesa; F Donato; N Portolani; M Favret; V Tomasoni; G Nardi
Journal:  Eur J Epidemiol       Date:  1995-08       Impact factor: 8.082

Review 9.  New advances in hepatocellular carcinoma.

Authors:  Sonia Pascual; Iván Herrera; Javier Irurzun
Journal:  World J Hepatol       Date:  2016-03-28

10.  Liveborn children and risk of hepatocellular carcinoma.

Authors:  A Tzonou; X Zavitsanos; C C Hsieh; D Trichopoulos
Journal:  Cancer Causes Control       Date:  1992-03       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.